 , Agents causing hyperkalemia , Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use , Antiarrhythmic agents , Antihypertensive Agents , Antihypertensive Agents Indicated for Hypertension , Benzazepines , Benzothiazepine Derivatives , Bradycardia-Causing Agents , Calcium Channel Blockers , Calcium Channel Blockers (Nondihydropyridine) , Calcium-Regulating Hormones and Agents , Cardiovascular Agents , Cytochrome P-450 CYP2C19 Substrates , Cytochrome P-450 CYP2C8 Inhibitors , Cytochrome P-450 CYP2C8 Inhibitors (moderate) , Cytochrome P-450 CYP2C8 Substrates , Cytochrome P-450 CYP2C9 Substrates , Cytochrome P-450 CYP2D6 Substrates , Cytochrome P-450 CYP3A Inhibitors , Cytochrome P-450 CYP3A Substrates , Cytochrome P-450 CYP3A4 Inhibitors , Cytochrome P-450 CYP3A4 Inhibitors (moderate) , Cytochrome P-450 CYP3A4 Inhibitors (strong) , Cytochrome P-450 CYP3A4 Substrates , Cytochrome P-450 CYP3A5 Inhibitors , Cytochrome P-450 CYP3A5 Inhibitors (moderate) , Cytochrome P-450 CYP3A5 Substrates , Cytochrome P-450 CYP3A7 Inhibitors , Cytochrome P-450 CYP3A7 Inhibitors (moderate) , Cytochrome P-450 CYP3A7 Inhibitors (strong) , Cytochrome P-450 CYP3A7 Substrates , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Substrates , Drugs causing inadvertant photosensitivity , Heterocyclic Compounds, Fused-Ring , Hypotensive Agents , Membrane Transport Modulators , Miscellaneous Calcium-channel Blocking Agents , Moderate Risk QTc-Prolonging Agents , P-glycoprotein inhibitors , P-glycoprotein substrates , Photosensitizing Agents , QTc Prolonging Agents , Selective Calcium Channel Blockers With Direct Cardiac Effects , Vasodilating Agents , Vasoprotectives